Telesis Bio, Inc.
Novel Codon-Optimized CFTR MRNA
Last updated:
Abstract:
The present invention provides, among other things, improved methods and pharmaceutical compositions for treating cystic fibrosis based on codon optimized mRNA encoding a Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein.
Status:
Application
Type:
Utility
Filling date:
6 Jan 2022
Issue date:
23 Jun 2022